|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q85774641
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000231.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q85774641
|
|
024
|
|
|
‡a
0000-0002-0916-2722
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q85774641
|
|
100
|
0 |
|
‡a
David Aguilar
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
David Aguilar
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A Multi-Trait Approach Identified Genetic Variants Including a Rare Mutation in RGS3 with Impact on Abnormalities of Cardiac Structure/Function
|
|
670
|
|
|
‡a
Author's A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance
|
|
670
|
|
|
‡a
Author's Abnormal rhythms in patients without known cardiac disease after a first dose of fingolimod.
|
|
670
|
|
|
‡a
Author's ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging theme
|
|
670
|
|
|
‡a
Author's Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study
|
|
670
|
|
|
‡a
Author's Antihypertensive drug use and blood pressure control among stroke survivors in the United States: NHANES 2003-2014
|
|
670
|
|
|
‡a
Author's Association of Serum Folate Levels With Cardiovascular Mortality Among Adults With Rheumatoid Arthritis
|
|
670
|
|
|
‡a
Author's Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study
|
|
670
|
|
|
‡a
Author's Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities).
|
|
670
|
|
|
‡a
Author's Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study
|
|
670
|
|
|
‡a
Author's Chagas cardiomyopathy is associated with higher incidence of stroke: a meta-analysis of observational studies
|
|
670
|
|
|
‡a
Author's Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement
|
|
670
|
|
|
‡a
Author's Correlates of Segmental Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
|
|
670
|
|
|
‡a
Author's Corrigendum to "Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America" Journal of Cardiac Failure Vol. 25 No. 8, pp. 584-619
|
|
670
|
|
|
‡a
Author's Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial.
|
|
670
|
|
|
‡a
Author's Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction
|
|
670
|
|
|
‡a
Author's Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease
|
|
670
|
|
|
‡a
Author's Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
|
|
670
|
|
|
‡a
Author's Functionally oriented analysis of cardiometabolic traits in a trans-ethnic sample
|
|
670
|
|
|
‡a
Author's Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities
|
|
670
|
|
|
‡a
Author's Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
|
|
670
|
|
|
‡a
Author's Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study
|
|
670
|
|
|
‡a
Author's Genome-Wide Association Study of Staphylococcus aureus Carriage in a Community-Based Sample of Mexican-Americans in Starr County, Texas
|
|
670
|
|
|
‡a
Author's Habitual physical activity and central artery stiffening in older adults: the Atherosclerosis Risk in Communities study
|
|
670
|
|
|
‡a
Author's Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease: A Clinical Conundrum.
|
|
670
|
|
|
‡a
Author's Improving Outcomes in Patients With Diabetes Mellitus
|
|
670
|
|
|
‡a
Author's Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study
|
|
670
|
|
|
‡a
Author's Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study
|
|
670
|
|
|
‡a
Author's Metabolomic profiles associated with subtypes of prediabetes among Mexican Americans in Starr County, Texas, USA
|
|
670
|
|
|
‡a
Author's Metformin use and mortality in ambulatory patients with diabetes and heart failure
|
|
670
|
|
|
‡a
Author's Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
|
|
670
|
|
|
‡a
Author's Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study
|
|
670
|
|
|
‡a
Author's Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease
|
|
670
|
|
|
‡a
Author's Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
|
|
670
|
|
|
‡a
Author's Response to Letter Regarding Article, “Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk In the Community Study”
|
|
670
|
|
|
‡a
Author's Sleep apnea and galectin-3: possible sex-specific relationship
|
|
670
|
|
|
‡a
Author's Smoking Behaviors and Arterial Stiffness Measured by Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities
|
|
670
|
|
|
‡a
Author's Smoking Behaviors and Arterial Stiffness Measured by Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
|
|
670
|
|
|
‡a
Author's Strategies of Unloading the Failing Heart from Metabolic Stress
|
|
670
|
|
|
‡a
Author's Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
|
|
670
|
|
|
‡a
Author's Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus.
|
|
670
|
|
|
‡a
Author's Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America
|
|
670
|
|
|
‡a
Author's Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
|
|
670
|
|
|
‡a
Author's Understanding by General Providers of the Echocardiogram Report
|
|
909
|
|
|
‡a
(orcid) 0000000209162722
‡9
1
|
|
912
|
|
|
‡a
erratumsequencedataandassociationstatisticsfrom12940type2diabetescasesandcontrols
‡A
Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
‡9
1
|
|
919
|
|
|
‡a
multitraitapproachidentifiedgeneticvariantsincludingararemutationinrgs3withimpactonabnormalitiesofcardiacstructurefunction
‡A
A Multi-Trait Approach Identified Genetic Variants Including a Rare Mutation in RGS3 with Impact on Abnormalities of Cardiac Structure/Function
‡9
1
|
|
919
|
|
|
‡a
prospectiveechocardiographicevaluationofpulmonaryhypertensioninchronichemodialysispatientsintheunitedstatesprevalenceandclinicalsignificance
‡A
A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance
‡9
1
|
|
919
|
|
|
‡a
abnormalrhythmsinpatientswithoutknowncardiacdiseaseaftera1doseoffingolimod
‡A
Abnormal rhythms in patients without known cardiac disease after a first dose of fingolimod.
‡9
1
|
|
919
|
|
|
‡a
aceinhibitorsandangiotensinreceptorantagonistsandtheincidenceofnewonsetdiabetesmellitusanemergingtheme
‡A
ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging theme
‡9
1
|
|
919
|
|
|
‡a
alcoholconsumptionandriskofheartfailuretheatherosclerosisriskincommunitiesstudy
‡A
Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study
‡9
1
|
|
919
|
|
|
‡a
antihypertensivedruguseandbloodpressurecontrolamongstrokesurvivorsintheunitedstatesnhanes2003
‡A
Antihypertensive drug use and blood pressure control among stroke survivors in the United States: NHANES 2003-2014
‡9
1
|
|
919
|
|
|
‡a
associationofserumfolatelevelswithcardiovascularmortalityamongadultswithrheumatoidarthritis
‡A
Association of Serum Folate Levels With Cardiovascular Mortality Among Adults With Rheumatoid Arthritis
‡9
1
|
|
919
|
|
|
‡a
associationofweightandbodycompositiononcardiacstructureandfunctioninthearicstudy
‡A
Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study
‡9
1
|
|
919
|
|
|
‡a
associationofweightandbodycompositiononcardiacstructureandfunctioninthearicstudyatherosclerosisriskincommunities
‡A
Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities).
‡9
1
|
|
919
|
|
|
‡a
cardiacstructureandfunctionacrosstheglycemicspectruminelderlymenandwomenfreeofprevalentheartdiseasetheatherosclerosisriskinthecommunitystudy
‡A
Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study
‡9
1
|
|
919
|
|
|
‡a
chagascardiomyopathyisassociatedwithhigherincidenceofstrokeametaanalysisofobservationalstudies
‡A
Chagas cardiomyopathy is associated with higher incidence of stroke: a meta-analysis of observational studies
‡9
1
|
|
919
|
|
|
‡a
congestiveheartfailureanddiabetesmellitusbalancingglycemiccontrolwithheartfailureimprovement
‡A
Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement
‡9
1
|
|
919
|
|
|
‡a
correlatesofsegmentalpulsewavevelocityinolderadultstheatherosclerosisriskincommunitiesaricstudy
‡A
Correlates of Segmental Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
‡9
1
|
|
919
|
|
|
‡a
corrigendumtotype2diabetesmellitusandheartfailureascientificstatementfromtheamericanheartassociationandheartfailuresocietyofamericajournalofcardiacfailurevol25no8pp584619
‡A
Corrigendum to "Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America" Journal of Cardiac Failure Vol. 25 No. 8, pp. 584-619
‡9
1
|
|
919
|
|
|
‡a
echocardiographicchangesduringtreatmentofacutedecompensatedheartfailureinsightsfromtheescapetrial
‡A
Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial.
‡9
1
|
|
919
|
|
|
‡a
editorschoiceimpactofinsulintreateddiabetesoncardiovascularoutcomesfollowinghighriskmyocardialinfarction
‡A
Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction
‡9
1
|
|
919
|
|
|
‡a
effectsof11weeklyexenatideonclinicaloutcomesinpatientswithpreexistingcardiovasculardisease
‡A
Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease
‡9
1
|
|
919
|
|
|
‡a
functionallyorientedanalysisofcardiometabolictraitsinatransethnicsample
‡A
Functionally oriented analysis of cardiometabolic traits in a trans-ethnic sample
‡9
1
|
|
919
|
|
|
‡a
galectin3andincidenceofatrialfibrillationtheatherosclerosisriskincommunities
‡A
Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities
‡9
1
|
|
919
|
|
|
‡a
galectin3andincidenceofatrialfibrillationtheatherosclerosisriskincommunitiesaricstudy
‡A
Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
‡9
1
|
|
919
|
|
|
‡a
galectin3andvenousthromboembolismincidencetheatherosclerosisriskincommunitiesaricstudy
‡A
Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study
‡9
1
|
|
919
|
|
|
‡a
genomewideassociationstudyofstaphylococcusaureuscarriageinacommunitybasedsampleofmexicanamericansinstarrcountytexas
‡A
Genome-Wide Association Study of Staphylococcus aureus Carriage in a Community-Based Sample of Mexican-Americans in Starr County, Texas
‡9
1
|
|
919
|
|
|
‡a
habitualphysicalactivityandcentralarterystiffeninginolderadultstheatherosclerosisriskincommunitiesstudy
‡A
Habitual physical activity and central artery stiffening in older adults: the Atherosclerosis Risk in Communities study
‡9
1
|
|
919
|
|
|
‡a
heartfailurediabetesmellitusandchronickidneydiseaseaclinicalconundrum
‡A
Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease: A Clinical Conundrum.
‡9
1
|
|
919
|
|
|
‡a
improvingoutcomesinpatientswithdiabetesmellitus
‡A
Improving Outcomes in Patients With Diabetes Mellitus
‡9
1
|
|
919
|
|
|
‡a
levelsandchangeingalectin3andassociationwithcardiovasculareventsthearicstudy
‡A
Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study
‡9
1
|
|
919
|
|
|
‡a
lifestylemodificationwithdietandexerciseinobesepatientswithheartfailureapilotstudy
‡A
Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study
‡9
1
|
|
919
|
|
|
‡a
metabolomicprofilesassociatedwithsubtypesofprediabetesamongmexicanamericansinstarrcountytexasusa
‡A
Metabolomic profiles associated with subtypes of prediabetes among Mexican Americans in Starr County, Texas, USA
‡9
1
|
|
919
|
|
|
‡a
metforminuseandmortalityinambulatorypatientswithdiabetesandheartfailure
‡A
Metformin use and mortality in ambulatory patients with diabetes and heart failure
‡9
1
|
|
919
|
|
|
‡a
natriureticpeptideandhighsensitivitytroponinforcardiovascularriskpredictionindiabetestheatherosclerosisriskincommunitiesaricstudy
‡A
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
‡9
1
|
|
919
|
|
|
‡a
plasmagalectin3andsonographicmeasuresofcarotidatherosclerosisintheatherosclerosisriskincommunitiesstudy
‡A
Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study
‡9
1
|
|
919
|
|
|
‡a
plasmagalectin3levelsareassociatedwiththeriskofincidentchronickidneydisease
‡A
Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease
‡9
1
|
|
919
|
|
|
‡a
rationaledesignandbaselinecharacteristicsinevaluationoflixisenatideinacutecoronarysyndromealongtermcardiovascularendpointtrialoflixisenatideversusplacebo
‡A
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
‡9
1
|
|
919
|
|
|
‡a
responsetoletterregardingarticlecardiacstructureandfunctionacrosstheglycemicspectruminelderlymenandwomenfreeofprevalentheartdiseasetheatherosclerosisriskinthecommunitystudy
‡A
Response to Letter Regarding Article, “Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk In the Community Study”
‡9
1
|
|
919
|
|
|
‡a
sleepapneaandgalectin3possiblesexspecificrelationship
‡A
Sleep apnea and galectin-3: possible sex-specific relationship
‡9
1
|
|
919
|
|
|
‡a
smokingbehaviorsandarterialstiffnessmeasuredbypulsewavevelocityinolderadultstheatherosclerosisriskincommunities
‡A
Smoking Behaviors and Arterial Stiffness Measured by Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities
‡9
1
|
|
919
|
|
|
‡a
smokingbehaviorsandarterialstiffnessmeasuredbypulsewavevelocityinolderadultstheatherosclerosisriskincommunitiesaricstudy
‡A
Smoking Behaviors and Arterial Stiffness Measured by Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
‡9
1
|
|
919
|
|
|
‡a
strategiesofunloadingthefailingheartfrommetabolicstress
‡A
Strategies of Unloading the Failing Heart from Metabolic Stress
‡9
1
|
|
919
|
|
|
‡a
takingtheairoutofoxygensupplementationinindividualswithdiabetesandacutecoronarysyndromes
‡A
Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
‡9
1
|
|
919
|
|
|
‡a
treatingdiseasemechanismsinpatientswithheartfailureanddiabetesmellitus
‡A
Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus.
‡9
1
|
|
919
|
|
|
‡a
type2diabetesmellitusandheartfailureascientificstatementfromtheamericanheartassociationandheartfailuresocietyofamerica
‡A
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America
‡9
1
|
|
919
|
|
|
‡a
type2diabetesmellitusandheartfailureascientificstatementfromtheamericanheartassociationandtheheartfailuresocietyofamericathisstatementdoesnotrepresentanupdateofthe2017accahahfsaheartfailureguidelineupdate
‡A
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
‡9
1
|
|
919
|
|
|
‡a
understandingbygeneralprovidersoftheechocardiogramreport
‡A
Understanding by General Providers of the Echocardiogram Report
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2014
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
PLWABN|9812798498405606
|
|
996
|
|
|
‡2
LC|no2016053439
|
|
996
|
|
|
‡2
LC|ns2023000278
|
|
996
|
|
|
‡2
BNC|981061121476806706
|
|
996
|
|
|
‡2
NSK|000500318
|
|
996
|
|
|
‡2
ISNI|0000000359622667
|
|
996
|
|
|
‡2
LC|no2022090250
|
|
996
|
|
|
‡2
LC|no2015096558
|
|
996
|
|
|
‡2
LC|n 98000821
|
|
996
|
|
|
‡2
PLWABN|9813657995005606
|
|
996
|
|
|
‡2
BNE|XX1681093
|
|
996
|
|
|
‡2
NTA|133631931
|
|
996
|
|
|
‡2
SUDOC|080557570
|
|
996
|
|
|
‡2
LC|n 2022059492
|
|
996
|
|
|
‡2
ISNI|000000046739995X
|
|
996
|
|
|
‡2
BNE|XX5629913
|
|
996
|
|
|
‡2
DNB|134793331
|
|
996
|
|
|
‡2
NUKAT|n 2010106907
|
|
996
|
|
|
‡2
BNCHL|10000000000000000871315
|
|
996
|
|
|
‡2
ISNI|000000011431448X
|
|
996
|
|
|
‡2
LC|ns2017001144
|
|
996
|
|
|
‡2
PTBNP|1433762
|
|
996
|
|
|
‡2
CAOONL|ncf13717174
|
|
996
|
|
|
‡2
NUKAT|n 2018107794
|
|
996
|
|
|
‡2
DNB|1056433752
|
|
996
|
|
|
‡2
LC|no2021083497
|
|
996
|
|
|
‡2
ISNI|0000000509721629
|
|
996
|
|
|
‡2
LC|n 2007052697
|
|
996
|
|
|
‡2
BNF|15812333
|
|
996
|
|
|
‡2
J9U|987007419234705171
|
|
996
|
|
|
‡2
BNE|XX6438783
|
|
996
|
|
|
‡2
BNC|981059719463206706
|
|
996
|
|
|
‡2
SUDOC|252896246
|
|
996
|
|
|
‡2
ISNI|0000000059296804
|
|
996
|
|
|
‡2
ISNI|0000000444385635
|
|
996
|
|
|
‡2
SUDOC|195390245
|
|
996
|
|
|
‡2
J9U|987008553578605171
|
|
996
|
|
|
‡2
W2Z|9015722
|
|
996
|
|
|
‡2
NDL|032079432
|
|
996
|
|
|
‡2
DNB|1153085984
|
|
996
|
|
|
‡2
LC|n 94070038
|
|
996
|
|
|
‡2
DNB|128062826X
|
|
996
|
|
|
‡2
BNE|XX4746589
|
|
996
|
|
|
‡2
KRNLK|KAC200812365
|
|
996
|
|
|
‡2
LC|n 2017011981
|
|
996
|
|
|
‡2
BNE|XX5427594
|
|
996
|
|
|
‡2
BNE|XX1579555
|
|
996
|
|
|
‡2
CAOONL|ncf11004367
|
|
996
|
|
|
‡2
BNE|XX5229257
|
|
996
|
|
|
‡2
DNB|1309638128
|
|
996
|
|
|
‡2
BIBSYS|9015722
|
|
996
|
|
|
‡2
CAOONL|ncf10652706
|
|
996
|
|
|
‡2
LC|no2018098992
|
|
996
|
|
|
‡2
LC|no2010115741
|
|
996
|
|
|
‡2
BIBSYS|97028794
|
|
996
|
|
|
‡2
J9U|987007436297905171
|
|
996
|
|
|
‡2
BNC|981058514761606706
|
|
996
|
|
|
‡2
BNC|981061093988806706
|
|
996
|
|
|
‡2
ISNI|0000000037937615
|
|
996
|
|
|
‡2
BNF|18055696
|
|
996
|
|
|
‡2
NTA|41770948X
|
|
996
|
|
|
‡2
DNB|1310961794
|
|
996
|
|
|
‡2
ISNI|0000000435401410
|
|
996
|
|
|
‡2
SUDOC|131049240
|
|
996
|
|
|
‡2
BNF|16767833
|
|
996
|
|
|
‡2
ISNI|0000000053937930
|
|
996
|
|
|
‡2
NTA|129610348
|
|
996
|
|
|
‡2
ISNI|0000000032503754
|
|
996
|
|
|
‡2
LC|no2019154789
|
|
996
|
|
|
‡2
BNC|981060869276006706
|
|
996
|
|
|
‡2
LC|no2019082834
|
|
996
|
|
|
‡2
DNB|1103361805
|
|
996
|
|
|
‡2
DNB|1082257818
|
|
996
|
|
|
‡2
BNC|981058510016306706
|
|
996
|
|
|
‡2
SUDOC|112573193
|
|
996
|
|
|
‡2
BNE|XX1773647
|
|
996
|
|
|
‡2
BNCHL|10000000000000000861916
|
|
996
|
|
|
‡2
ISNI|0000000115981241
|
|
996
|
|
|
‡2
BNF|14560815
|
|
996
|
|
|
‡2
LC|nr2003034114
|
|
996
|
|
|
‡2
LC|n 93060055
|
|
996
|
|
|
‡2
NII|DB00018579
|
|
996
|
|
|
‡2
NUKAT|n 2018133535
|
|
996
|
|
|
‡2
LC|no2007026708
|
|
996
|
|
|
‡2
BNE|XX963555
|
|
996
|
|
|
‡2
BNE|XX1172133
|
|
996
|
|
|
‡2
LC|no2006128906
|
|
996
|
|
|
‡2
DNB|1256955337
|
|
996
|
|
|
‡2
ISNI|0000000451183097
|
|
996
|
|
|
‡2
SUDOC|26785837X
|
|
996
|
|
|
‡2
PLWABN|9810624772005606
|
|
996
|
|
|
‡2
DBC|87097990023268
|
|
996
|
|
|
‡2
BNE|XX5453400
|
|
996
|
|
|
‡2
DNB|1122065035
|
|
996
|
|
|
‡2
ISNI|0000000103165888
|
|
996
|
|
|
‡2
ISNI|0000000036439884
|
|
996
|
|
|
‡2
ISNI|0000000003517233
|
|
996
|
|
|
‡2
BNE|XX5404762
|
|
996
|
|
|
‡2
RERO|A027532011
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
